Detalhe da pesquisa
1.
Low levels of minimal residual disease after induction chemotherapy for BCR-ABL1-negative acute lymphoblastic leukaemia in adults are clinically relevant.
Br J Haematol
; 196(3): 706-710, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34816424
2.
Genomic landscape of B-other acute lymphoblastic leukemia in an adult retrospective cohort with a focus on BCR-ABL1-like subtype.
Acta Oncol
; 60(6): 760-770, 2021 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-33750258
3.
Calreticulin exposure on malignant blasts correlates with improved natural killer cell-mediated cytotoxicity in acute myeloid leukemia patients.
Haematologica
; 105(7): 1868-1878, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31582537
4.
DNA Methylation Validation Methods: a Coherent Review with Practical Comparison.
Biol Proced Online
; 21: 19, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31582911
5.
High PD-L1 Expression Predicts for Worse Outcome of Leukemia Patients with Concomitant NPM1 and FLT3 Mutations.
Int J Mol Sci
; 20(11)2019 Jun 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31185600
6.
Rapid identification of BCR/ABL1-like acute lymphoblastic leukaemia patients using a predictive statistical model based on quantitative real time-polymerase chain reaction: clinical, prognostic and therapeutic implications.
Br J Haematol
; 181(5): 642-652, 2018 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29675955
7.
Calreticulin exposure by malignant blasts correlates with robust anticancer immunity and improved clinical outcome in AML patients.
Blood
; 128(26): 3113-3124, 2016 12 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-27802968
8.
Early MRD response as a prognostic factor in adult patients with acute lymphoblastic leukemia.
Eur J Haematol
; 96(3): 276-84, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25997106
9.
ABC transporters are predictors of treatment failure in acute myeloid leukaemia.
Biomed Pharmacother
; 170: 115930, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-38039756
10.
MethScore as a new comprehensive DNA methylation-based value refining the prognosis in acute myeloid leukemia.
Clin Epigenetics
; 16(1): 17, 2024 01 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-38254139
11.
Minimal residual disease detectable by quantitative assessment of WT1 gene before allogeneic stem cell transplantation in patients in first remission of acute myeloid leukemia has an impact on their future prognosis.
Clin Transplant
; 27(1): E21-9, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23231003
12.
Novel Somatic UBA1 Variant in a Patient With VEXAS Syndrome.
Arthritis Rheumatol
; 75(7): 1285-1290, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-36762418
13.
Type I interferon signaling in malignant blasts contributes to treatment efficacy in AML patients.
Cell Death Dis
; 14(3): 209, 2023 03 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-36964168
14.
Chimeric Antigen Receptor Based Cellular Therapy for Treatment Of T-Cell Malignancies.
Front Oncol
; 12: 876758, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35600381
15.
NPM1 and DNMT3A mutations are associated with distinct blast immunophenotype in acute myeloid leukemia.
Oncoimmunology
; 11(1): 2073050, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35558161
16.
A validation study of potential prognostic DNA methylation biomarkers in patients with acute myeloid leukemia using a custom DNA methylation sequencing panel.
Clin Epigenetics
; 14(1): 22, 2022 02 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35148810
17.
WT1 Gene Expression in Peripheral Blood Before and After Allogeneic Stem Cell Transplantation is a Clinically Relevant Prognostic Marker in AML - A Single-center 14-year Experience.
Clin Lymphoma Myeloma Leuk
; 21(2): e145-e151, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33160932
18.
TIM-3 levels correlate with enhanced NK cell cytotoxicity and improved clinical outcome in AML patients.
Oncoimmunology
; 10(1): 1889822, 2021 03 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33758676
19.
Somatic Mutations in Oncogenes Are in Chronic Myeloid Leukemia Acquired De Novo via Deregulated Base-Excision Repair and Alternative Non-Homologous End Joining.
Front Oncol
; 11: 744373, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34616685
20.
WT1 Expression in Peripheral Blood at Diagnosis and During the Course of Early Consolidation Treatment Correlates With Survival in Patients With Intermediate and Poor-Risk Acute Myeloid Leukemia.
Clin Lymphoma Myeloma Leuk
; 20(12): e998-e1009, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32888885